PTCT PTC Therapeutics, Inc. | US69366J2006
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 1.343.729.940 | 1.182.592.100 | 13.63% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 2,74 | 1,32 | 107.58% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 3 | 3 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |